GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis India Ltd (BOM:500672) » Definitions » 3-Year RORE %

Novartis India (BOM:500672) 3-Year RORE % : 12.64% (As of Sep. 2024)


View and export this data going back to 1991. Start your Free Trial

What is Novartis India 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Novartis India's 3-Year RORE % for the quarter that ended in Sep. 2024 was 12.64%.

The industry rank for Novartis India's 3-Year RORE % or its related term are showing as below:

BOM:500672's 3-Year RORE % is ranked better than
64.21% of 978 companies
in the Drug Manufacturers industry
Industry Median: -1.65 vs BOM:500672: 12.64

Novartis India 3-Year RORE % Historical Data

The historical data trend for Novartis India's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis India 3-Year RORE % Chart

Novartis India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -103.77 -356.41 29.47 177.65 80.33

Novartis India Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 77.76 69.21 62.60 80.33 12.64

Competitive Comparison of Novartis India's 3-Year RORE %

For the Drug Manufacturers - Specialty & Generic subindustry, Novartis India's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis India's 3-Year RORE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis India's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Novartis India's 3-Year RORE % falls into.



Novartis India 3-Year RORE % Calculation

Novartis India's 3-Year RORE % for the quarter that ended in Sep. 2024 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 24.97-21.74 )/( 80.55-55 )
=3.23/25.55
=12.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2024 and 3-year before.


Novartis India  (BOM:500672) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Novartis India 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of Novartis India's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis India Business Description

Traded in Other Exchanges
N/A
Address
Inspire BKC, Part of 601 & 701, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Novartis India Ltd is an Indian-based pharmaceutical company. The company is engaged in the trading of Drugs and Pharmaceuticals. It derives revenue from operations in India. The company operates in a single business segment namely Pharmaceutical Business, Its Pharmaceutical business focuses on Bone and Pain, Transplantation Immunology, and Neurosciences.

Novartis India Headlines

No Headlines